1
|
Zhang X, Sun H, Han C, Wang H, Zhang J, Zhang D, Lin B, Hua H, Cheng M, Liu Y. Asymmetric Total Synthesis of Neobraclactone C. Org Lett 2022; 24:9485-9490. [PMID: 36520595 DOI: 10.1021/acs.orglett.2c03970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Asymmetric total synthesis of neobraclactone C was finished for the first time using the convergent synthetic strategy in 22 steps in the longest linear sequence from known materials. The key steps include a steric hindrance/hydrogen bond dual-controlled Heck arylation of α,β-unsaturated ketone to construct hemiketal and cis-alkenyl in one step and a CeCl3-catalyzed tricycle formation.
Collapse
Affiliation(s)
- Xinhang Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - Hanyang Sun
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - Changhong Han
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - He Wang
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - Junpeng Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - Di Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - Huiming Hua
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China.,Institute of Drug Research in Medicine Capital of China, Benxi, Liaoning 117000, People's Republic of China
| |
Collapse
|
2
|
Goggiamani A, Iazzetti A, Arcadi A, Calcaterra A, Chiarini M, Fabrizi G, Fochetti A, Marrone F, Marsicano V, Serraiocco A. Synthesis of Indole/Benzofuran-Containing Diarylmethanes through Palladium-Catalyzed Reaction of Indolylmethyl or Benzofuranylmethyl Acetates with Boronic Acids. SYNTHESIS-STUTTGART 2022. [DOI: 10.1055/s-0041-1737275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
AbstractThe palladium-catalyzed synthesis of indole/benzofuran-containing diarylmethanes starting from indolylmethyl or benzofuranylmethyl acetates with boronic acids has been investigated. The success of the reaction is influenced by the choice of precatalyst: with indolylmethyl acetates the reaction works well with [Pd(η3-C3H5)Cl]2/XPhos while with benzofuranylmethyl acetates Pd2(dba)3/XPhos is more efficient. The good to high yields and the simplicity of the experimental procedure make this protocol a versatile synthetic tool for the preparation of 2- and 3-substituted indoles and 2-benzo[b]furans. The methodology can be advantageously extended to the preparation of a key precursor of Zafirlukast.
Collapse
Affiliation(s)
| | - Antonia Iazzetti
- Dipartimento di Scienze Biotecnologiche di base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore
| | - Antonio Arcadi
- Dipartimento di Ingegneria e Scienze dell’Informazione e Matematica, Università degli studi di L’ Aquila
- Dipartimento di Scienze Fisiche e Chimiche, Università degli studi di L’ Aquila
| | - Andrea Calcaterra
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza, Università di Roma
| | - Marco Chiarini
- Università degli Studi di Teramo, Facoltà di Bioscienze e tecnologie agro-alimentari e ambientali
| | - Giancarlo Fabrizi
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza, Università di Roma
| | - Andrea Fochetti
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza, Università di Roma
| | - Federico Marrone
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza, Università di Roma
| | - Vincenzo Marsicano
- Dipartimento di Scienze Fisiche e Chimiche, Università degli studi di L’ Aquila
| | - Andrea Serraiocco
- Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza, Università di Roma
| |
Collapse
|